Barbara Ascione Selected Research

Barbara Ascione Research Topics

Disease

16	Neoplasms (Cancer) 04/2022 - 02/2005
5	Melanoma (Melanoma, Malignant) 04/2022 - 04/2002
3	Glioblastoma (Glioblastoma Multiforme) 11/2021 - 01/2018
2	Heart Failure 02/2022 - 01/2017
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 02/2022
1	Papillomavirus Infections 01/2021
1	Mental Disorders (Mental Disorder) 01/2021
1	Glioma (Gliomas) 01/2021
1	Brain Neoplasms (Brain Tumor) 01/2018
1	Lymphoma (Lymphomas) 01/2017
1	Infertility (Sterility) 01/2017
1	Hodgkin Disease (Hodgkin's Disease) 01/2017
1	Carcinogenesis 10/2013
1	Motor Disorders 12/2012
1	Gastroenteritis 12/2012
1	Human Influenza (Influenza) 12/2011
1	Neoplasm Metastasis (Metastasis) 08/2010
1	Endotoxemia 05/2010
1	Astrocytoma (Pilocytic Astrocytoma) 10/2009
1	Autoimmune Diseases (Autoimmune Disease) 02/2009
1	Kaposi Sarcoma (Kaposi's Sarcoma) 12/2007
1	Inflammation (Inflammations) 02/2005

Drug/Important Bio-Agent (IBA)

4	Biological ProductsIBA 01/2021 - 08/2010
4	Pharmaceutical PreparationsIBA 12/2019 - 12/2007
3	CathepsinsIBA 12/2011 - 04/2002
2	Isoproterenol (Isoprenaline)FDA LinkGeneric 04/2022 - 01/2022
2	Doxorubicin (Adriamycin)FDA LinkGeneric 02/2022 - 11/2019
2	Chlorpromazine (Thorazine)FDA Link 11/2021 - 01/2021
2	Temozolomide (Temodar)FDA LinkGeneric 01/2021 - 01/2018
2	Oncogene Proteins (Oncogene Protein)IBA 08/2016 - 10/2013
2	LipopolysaccharidesIBA 12/2012 - 05/2010
2	Peptide Hydrolases (Proteases)FDA Link 12/2011 - 08/2010
1	LuciferasesIBA 04/2022
1	Clonidine (ST 155)FDA LinkGeneric 04/2022
1	Antihypertensive Agents (Antihypertensives)IBA 04/2022
1	Estrogen Receptor betaIBA 02/2022
1	Silybin (Lagosa)IBA 02/2022
1	Epinephrine (Adrenaline)FDA LinkGeneric 01/2022
1	cirazolineIBA 01/2022
1	CatecholaminesIBA 01/2022
1	Adrenergic Receptors (Adrenergic Receptor)IBA 01/2022
1	LigandsIBA 01/2022
1	Reactive Oxygen Species (Oxygen Radicals)IBA 11/2021
1	Antipsychotic Agents (Antipsychotics)IBA 01/2021
1	Actins (F Actin)IBA 12/2019
1	Antineoplastic Agents (Antineoplastics)IBA 12/2019
1	TubulinIBA 12/2019
1	Interleukin-8 (Interleukin 8)IBA 11/2019
1	Interleukin-6 (Interleukin 6)IBA 11/2019
1	CytokinesIBA 11/2019
1	Monoclonal AntibodiesIBA 01/2018
1	2,3-bis(4-hydroxyphenyl)-propionitrileIBA 01/2017
1	Estrogens (Estrogen)FDA Link 01/2017
1	NAD (NADH)IBA 01/2017
1	Estrogen ReceptorsIBA 01/2017
1	GelsolinIBA 08/2016
1	DNA (Deoxyribonucleic Acid)IBA 08/2016
1	AntioxidantsIBA 12/2012
1	pepstatin (pepstatin A)IBA 12/2011
1	Antiviral Agents (Antivirals)IBA 12/2011
1	N- (3- propylcarbamoyloxirane- 2- carbonyl)- isoleucyl- prolineIBA 08/2010
1	AntibodiesIBA 08/2010
1	Cathepsin BIBA 08/2010
1	Toll-Like Receptor 4IBA 05/2010
1	Interferon-gamma (Interferon, gamma)IBA 10/2009
1	ZymosanIBA 02/2009
1	Tyrosine Kinase InhibitorsIBA 12/2007
1	Imatinib Mesylate (Gleevec)FDA Link 12/2007
1	Fas Ligand Protein (Fas Ligand)IBA 02/2005
1	1-nitrohydroxyphenyl-N-benzoylalanine (GAL 1)IBA 02/2005
1	InterferonsIBA 04/2002
1	StaurosporineIBA 04/2002
1	Interferon Type IIBA 04/2002
1	CaspasesIBA 04/2002
1	Cisplatin (Platino)FDA LinkGeneric 04/2002

Therapy/Procedure

6	Therapeutics 04/2022 - 04/2016
1	Drug Therapy (Chemotherapy) 01/2018
1	Radiotherapy 01/2017
1	Ligation 01/2017